UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males

The New England journal of medicine, 2011-02, Vol.364 (5), p.401-411

2011

Volltextzugriff (PDF)

Immunogenicity of the Quadrivalent Human Papillomavirus (Type 6/11/16/18) Vaccine in Males 16 to 26 Years Old

Clinical and Vaccine Immunology, 2012-02, Vol.19 (2), p.261-267

2012

Volltextzugriff (PDF)

Prevalence of Neutralizing Antibodies to Adenoviral Serotypes 5 and 35 in the Adult Populations of The Gambia, South Africa, and the United States

Clinical and Diagnostic Laboratory Immunology, 2004-03, Vol.11 (2), p.351-357

2004

Volltextzugriff (PDF)

The fine balance of the microbiome, immunology and allergy – may the microbiome always be with you

Current allergy & clinical immunology, 2019-06, Vol.32 (2), p.67-67

Vardas, Eftyhia

2019

Volltextzugriff (PDF)

The tangled web of the immune system : allergy and the microbiome

Current allergy & clinical immunology, 2019-06, Vol.32 (2), p.77-81

Vardas, Eftyhia

2019

Volltextzugriff (PDF)

Allergic rhinitis: Review of the diagnosis and management: South African Allergic Rhinitis Working Group

South African family practice, 2023-01, Vol.65 (1), p.e1-11

2023

Volltextzugriff (PDF)

Molecular characterization of HIV-1 subtype C gp-120 regions potentially involved in virus adaptive mechanisms

PloS one, 2014-04, Vol.9 (4), p.e95183-e95183

2014

Volltextzugriff (PDF)

Intra- and inter-clade cross-reactivity by HIV-1 Gag specific T-cells reveals exclusive and commonly targeted regions: implications for current vaccine trials

PloS one, 2011-10, Vol.6 (10), p.e26096-e26096

2011

Volltextzugriff (PDF)

Safety and reactogenicity of a quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 viral-like-particle vaccine in older adolescents and young adults

Human vaccines, 2011-07, Vol.7 (7), p.768-775

2011

Volltextzugriff (PDF)

Using flow-cast testing for food- additive hypersensitivity at a private laboratory in South Africa

Current allergy & clinical immunology, 2020-12, Vol.33 (3-4), p.4-9

2020

Volltextzugriff (PDF)

Indicators of therapeutic effect in FIT-06, a Phase II trial of a DNA vaccine, GTU® -Multi-HIVB, in untreated HIV-1 infected subjects

Vaccine, 2012-06, Vol.30 (27), p.4046-4054

2012

Volltextzugriff (PDF)

Background morbidity in HIV vaccine trial participants from various geographic regions as assessed by unsolicited adverse events

Human vaccines & immunotherapeutics, 2012-05, Vol.8 (5), p.630-638

2012

Volltextzugriff (PDF)

Quadrivalent HPV vaccine efficacy against disease related to vaccine and non-vaccine HPV types in males

Vaccine, 2013-08, Vol.31 (37), p.3849-3855

2013

Volltextzugriff (PDF)

The effect of introduction of universal childhood hepatitis B immunization in South Africa on the prevalence of serologically negative hepatitis B virus infection and the selection of immune escape variants

Vaccine, 2001-07, Vol.19 (28), p.3912-3918

2001

Volltextzugriff (PDF)

External Genital Human Papillomavirus Prevalence and Associated Factors Among Heterosexual Men on 5 Continents

The Journal of infectious diseases, 2011-01, Vol.203 (1), p.58-65

2011

Volltextzugriff (PDF)

Human leukocyte antigen class I (A, B, C) and II (DRB1) diversity in the black and Caucasian South African population

Human immunology, 2012, Vol.73 (1), p.80-92

2012

Volltextzugriff (PDF)

Beyond the checklist: assessing understanding for HIV vaccine trial participation in South Africa

Journal of acquired immune deficiency syndromes (1999), 2006-12, Vol.43 (5), p.560-566

2006

Volltextzugriff (PDF)

The Impact of Human Immunodeficiency Virus Type 1 Status on Human Papillomavirus (HPV) Prevalence and HPV Antibodies in Serum and Cervical Secretions

The Journal of infectious diseases, 2000-10, Vol.182 (4), p.1239-1242

2000

Volltextzugriff (PDF)

Indicators of therapeutic effect in FIT-06, a Phase II trial of a DNA vaccine, GTUARG-Multi-HIVB, in untreated HIV-1 infected subjects

Vaccine, 2012-06, Vol.30 (27), p.4046-4054

2012

Volltextzugriff (PDF)

Case Report and Molecular Analysis of Subacute Sclerosing Panencephalitis in a South African Child

Journal of Clinical Microbiology, 1999-03, Vol.37 (3), p.775-777

1999

Volltextzugriff (PDF)

A phase 2 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 vaccine based on adeno-associated virus

AIDS research and human retroviruses, 2010-08, Vol.26 (8), p.933-942

2010

Volltextzugriff (PDF)

A new antigen scanning strategy for monitoring HIV-1 specific T-cell immune responses

Journal of immunological methods, 2012-01, Vol.375 (1-2), p.46-56

2012

Volltextzugriff (PDF)

Characterization of HIV type 1 genetic diversity among South African participants enrolled in the AIDS Vaccine Integrated Project (AVIP) study

AIDS research and human retroviruses, 2010-06, Vol.26 (6), p.705-709

2010

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(44)

Sprache

Englisch
(44)

Erscheinungsjahr

n.n

Thema

Science & Technology
(37)
Life Sciences & Biomedicine
(35)
Humans
(33)
Immunology
(25)
Biological And Medical Sciences
(22)
Infectious Diseases
(20)
Male
(20)
Virology
(20)
Microbiology
(19)
Adult
(18)
Medical Sciences
(17)
Female
(16)
Fundamental And Applied Biological Sciences. Psychology
(15)
Human Viral Diseases
(14)
Viral Diseases
(14)
Adolescent
(11)
South Africa
(11)
Vaccines
(11)
Hiv
(10)
Human Immunodeficiency Virus
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males

Immunogenicity of the Quadrivalent Human Papillomavirus (Type 6/11/16/18) Vaccine in Males 16 to 26 Years Old

Prevalence of Neutralizing Antibodies to Adenoviral Serotypes 5 and 35 in the Adult Populations of The Gambia, South Africa, and the United States

The fine balance of the microbiome, immunology and allergy – may the microbiome always be with you

The tangled web of the immune system : allergy and the microbiome

Allergic rhinitis: Review of the diagnosis and management: South African Allergic Rhinitis Working Group

Molecular characterization of HIV-1 subtype C gp-120 regions potentially involved in virus adaptive mechanisms

Intra- and inter-clade cross-reactivity by HIV-1 Gag specific T-cells reveals exclusive and commonly targeted regions: implications for current vaccine trials

Safety and reactogenicity of a quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 viral-like-particle vaccine in older adolescents and young adults

International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: Correlates of high Ad5 titers and implications for potential HIV vaccine trials

Using flow-cast testing for food- additive hypersensitivity at a private laboratory in South Africa

Indicators of therapeutic effect in FIT-06, a Phase II trial of a DNA vaccine, GTU® -Multi-HIVB, in untreated HIV-1 infected subjects

Background morbidity in HIV vaccine trial participants from various geographic regions as assessed by unsolicited adverse events

Quadrivalent HPV vaccine efficacy against disease related to vaccine and non-vaccine HPV types in males

The effect of introduction of universal childhood hepatitis B immunization in South Africa on the prevalence of serologically negative hepatitis B virus infection and the selection of immune escape variants

External Genital Human Papillomavirus Prevalence and Associated Factors Among Heterosexual Men on 5 Continents

Human leukocyte antigen class I (A, B, C) and II (DRB1) diversity in the black and Caucasian South African population

Beyond the checklist: assessing understanding for HIV vaccine trial participation in South Africa

The Impact of Human Immunodeficiency Virus Type 1 Status on Human Papillomavirus (HPV) Prevalence and HPV Antibodies in Serum and Cervical Secretions

Indicators of therapeutic effect in FIT-06, a Phase II trial of a DNA vaccine, GTUARG-Multi-HIVB, in untreated HIV-1 infected subjects

Studies of a prophylactic HIV-1 vaccine candidate based on modified vaccinia virus Ankara (MVA) with and without DNA priming: Effects of dosage and route on safety and immunogenicity

Case Report and Molecular Analysis of Subacute Sclerosing Panencephalitis in a South African Child

A phase 2 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 vaccine based on adeno-associated virus

A new antigen scanning strategy for monitoring HIV-1 specific T-cell immune responses

Characterization of HIV type 1 genetic diversity among South African participants enrolled in the AIDS Vaccine Integrated Project (AVIP) study

Suchergebnisse filtern